Valvuloplasty in the treatment of rheumatic tricuspid disease

Asian Cardiovasc Thorac Ann. 2008 Apr;16(2):107-11. doi: 10.1177/021849230801600205.

Abstract

Organic involvement of the tricuspid valve is uncommon. Valve repair is preferred over replacement as it results in a low gradient across the valve and obviates the risk of prosthesis-related complications. From October 2002 to October 2004, 37 patients who required tricuspid valve repair for organic involvement were included in this study. They were divided into 2 groups depending on the surgical procedure for valve repair: 20 patients in group 1 had tricuspid commissurotomy and De Vega annuloplasty; 17 in group 2 had tricuspid commissurotomy only. There were significant reductions in peak and mean tricuspid gradients and right ventricular systolic pressure in both groups. Annular shortening was similar in both groups (median, 23% in group 1, 21% in group 2), but the ratio of the tricuspid regurgitation jet area to right atrial area was greater in group 2 (median, 0.40 in group 2, 0.19 in group 1). There was no postoperative death. We recommend supporting the tricuspid annulus with annuloplasty in patients with organic tricuspid valve disease and no dilatation of the annulus, if annular shortening is < 30%.

MeSH terms

  • Adult
  • Cardiac Surgical Procedures*
  • Female
  • Follow-Up Studies
  • Hemodynamics
  • Humans
  • Male
  • Patient Selection
  • Retrospective Studies
  • Rheumatic Heart Disease / physiopathology
  • Rheumatic Heart Disease / surgery*
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome
  • Tricuspid Valve / physiopathology
  • Tricuspid Valve / surgery*
  • Tricuspid Valve Insufficiency / physiopathology
  • Tricuspid Valve Insufficiency / surgery*
  • Ventricular Function, Right
  • Ventricular Pressure